Modular bioprinting for advanced 3D in vitro research

Build morehuman-relevantmodels.

JetBio brings distinctive ReJI, microvalve and inkjet printing together in one adaptable platform, supported by people who help shape the application around your biology.

01 ReJI02 Microvalve03 Inkjet

Start with a confidential application discussion. No fixed specification or purchase commitment required.

Close-up of JetBio bioprinting technology in the laboratory
Three print modesOne adaptable research platform
3complementary print modes
3university research deployments
ReJIdistinctive high-density print process
NC3Rsbacked 3D in vitro programme

Choose the right next step

What brings you to JetBio?

Looking at JetBio as an investor or strategic partner? Review the commercial case

Start with the model

Your next experiment should not be dictated by your printer.

Advanced biology rarely fits a single material, cell type or deposition method. JetBio is being developed to give research teams more freedom to combine methods around the question they need to answer.

01

Recreate cellular microenvironments

Place cell-filled hydrogels where they are needed, with a pathway towards dense, structured 3D cultures.

03

Work in relevant lab formats

Develop models around multiwell plates, selected substrates and the workflow your team already understands.

The JetBio platform

Three ways to print. One adaptable system.

Select the print mode for each job, then build a workflow around your cells, materials, geometry and readout.

R

Distinctive process

ReJI

Two liquid streams meet in flight to form cell-filled gel droplets before deposition.

See how ReJI works
M

Controlled dispensing

Microvalve

Controlled droplet deposition for repeatable patterning and multiwell workflows.

Explore the architecture
Precision nozzles within the JetBio research system

One system is only useful if it fits the scientific workflow.

Explore the full platform

Application-led by design

Where could a more adaptable model take your research?

JetBio’s first commercial conversations focus on applications where model architecture, cell density and workflow fit matter most.

These examples are development pathways, not claims of validated customer outcomes. Suitability is established through application review and feasibility work.

Explore the application pathways
MiniREJI research system installed in a laboratoryMiniREJI in a research laboratory

Evidence before adjectives

Commercial confidence starts with what can be shown.

JetBio’s current evidence base includes the distinctive ReJI process and NC3Rs-backed research deployments with Newcastle, Bristol and Cambridge universities.

  • Application development in real research environments
  • Direct feedback from scientific users
  • Commercial specifications shaped by feasibility data

Current status These are research deployments and application-development activities, not commercial sales.

Review the evidence pathway

Peer-reviewed foundations

Research you can trace.

JetBio’s ReJI platform is grounded in published work on high-cell-density gels, process characterisation and structured biological models.

Browse the publication library

Publications establish scientific foundations and application findings. They do not replace application-specific feasibility, reproducibility or commercial validation.

A lower-risk way to start

From biological question to a scoped feasibility project.

No premature product pitch. First we establish whether JetBio’s print modes and development pathway fit the model you are trying to build.

  1. 01

    Discuss

    Share the model, material, cell and readout requirements.

  2. 02

    Define

    Agree success criteria, constraints and the most relevant print mode.

  3. 03

    Evaluate

    Scope a feasibility study with evidence gates and responsibilities.

  4. 04

    Progress

    Use results to inform configuration, onboarding and the next commercial step.

Bioprinting knowledge

Make the method fit the biological question.

Clear, evidence-aware guidance on 3D bioprinting methods, model design and the qualification steps drug discovery teams need.

Start a useful conversation

Bring us the model you cannot build today.

Tell us where your current workflow falls short. We will help you assess whether JetBio is a credible route forward.

Discuss your model